127 related articles for article (PubMed ID: 1879977)
1. Double-blind randomised placebo-controlled dose-efficacy study of sustained release verapamil in chronic stable angina.
Gibbs JS; McAlpine HM; Wright C; McLenachan JM; Sparrow J; Sutton G; Dargie HJ; Fox KM
Int J Cardiol; 1991 Jun; 31(3):281-6. PubMed ID: 1879977
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of sustained-release verapamil in chronic stable angina pectoris.
Weiner DA; Klein MD; Cutler SS
Am J Cardiol; 1987 Feb; 59(4):215-8. PubMed ID: 3544792
[TBL] [Abstract][Full Text] [Related]
3. Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris.
Cutler NR; Anders RJ; Jhee SS; Sramek JJ; Awan NA; Bultas J; Lahiri A; Woroszylska M
Am J Cardiol; 1995 Jun; 75(16):1102-6. PubMed ID: 7762493
[TBL] [Abstract][Full Text] [Related]
4. Sustained-release verapamil and nifedipine in exercise-induced angina pectoris.
Foale RA; Vandenburg MJ
Eur Heart J; 1992 Feb; 13(2):256-60. PubMed ID: 1555625
[TBL] [Abstract][Full Text] [Related]
5. Sustained release verapamil, a once daily preparation: objective evaluation using exercise testing, ambulatory monitoring and blood levels in patients with stable angina.
Kohli RS; Rodrigues EA; Hughes LO; Lahiri A; Raftery EB
J Am Coll Cardiol; 1987 Mar; 9(3):615-21. PubMed ID: 3102585
[TBL] [Abstract][Full Text] [Related]
6. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
[TBL] [Abstract][Full Text] [Related]
7. Effects of a transdermal patch system containing nitroglycerin on exercise tolerance in patients with angina pectoris. Double-blind, placebo controlled, comparison with slow-release nifedipine and verapamil.
Gibelli G; Negrini M; Mazzocchi F; Prina L; Pollavini P; De Ponti C
G Ital Cardiol; 1986 Nov; 16(11):904-8. PubMed ID: 3104124
[TBL] [Abstract][Full Text] [Related]
8. Sustained-release and instant-release verapamil in treatment of angina pectoris.
Jespersen CM; Klitgaard NA; Nielsen H; Hansen JF
Eur J Clin Pharmacol; 1989; 36(6):625-7. PubMed ID: 2776821
[TBL] [Abstract][Full Text] [Related]
9. A comparison of sustained release verapamil versus atenolol for 24 h protection from exercise-induced angina pectoris.
Hopkinson ND; Hui KP; Smith MP; Hollinrake K
Eur Heart J; 1991 Dec; 12(12):1273-7. PubMed ID: 1778191
[TBL] [Abstract][Full Text] [Related]
10. Antianginal efficacy over 24 hours and exercise hemodynamic effects of once daily sustained-release 300 mg diltiazem and 240 mg verapamil in stable angina pectoris.
De Rosa ML; Giordano A; Melfi M; Della Guardia D; Ciaburri F; Rengo F
Int J Cardiol; 1998 Jan; 63(1):27-35. PubMed ID: 9482142
[TBL] [Abstract][Full Text] [Related]
11. Differences in response to single dose and steady-state therapy with verapamil in stable angina.
Vazquez de Prada JA; Zueco J; Ruano J; Martin-Duran R; Sanjose JM; Colman T; Pajaron A
Int J Cardiol; 1991 Sep; 32(3):339-45. PubMed ID: 1791086
[TBL] [Abstract][Full Text] [Related]
12. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
[TBL] [Abstract][Full Text] [Related]
13. A double blind placebo controlled comparison of verapamil, atenolol, and their combination in patients with chronic stable angina pectoris.
Findlay IN; MacLeod K; Gillen G; Elliott AT; Aitchison T; Dargie HJ
Br Heart J; 1987 Apr; 57(4):336-43. PubMed ID: 3555566
[TBL] [Abstract][Full Text] [Related]
14. Verapamil administered twice daily in stable angina pectoris.
Tan AT; Quek S
Chest; 1984 Jan; 85(1):55-8. PubMed ID: 6360575
[TBL] [Abstract][Full Text] [Related]
15. Verapamil in chronic stable angina. A controlled study with computerized multistage treadmill exercise.
Subramanian VB; Lahiri A; Paramasivan R; Raftery EB
Lancet; 1980 Apr; 1(8173):841-4. PubMed ID: 6103208
[TBL] [Abstract][Full Text] [Related]
16. A controlled trial of verapamil for Prinzmetal's variant angina.
Johnson SM; Mauritson DR; Willerson JT; Hillis LD
N Engl J Med; 1981 Apr; 304(15):862-6. PubMed ID: 6782480
[TBL] [Abstract][Full Text] [Related]
17. Randomized double-blind comparison of the effects of isosorbide dinitrate retard, verapamil sustained-release, and their combination on myocardial ischemic episodes.
Friedensohn A; Meshulam R; Schlesinger Z
Cardiology; 1991; 79 Suppl 2():31-40. PubMed ID: 1760827
[TBL] [Abstract][Full Text] [Related]
18. Long-term effectiveness of verapamil in stable and unstable angina pectoris. One-year follow-up of patients treated in placebo-controlled double-blind randomized clinical trials.
Scheidt S; Frishman WH; Packer M; Mehta J; Parodi O; Subramanian VB
Am J Cardiol; 1982 Nov; 50(5):1185-90. PubMed ID: 6814226
[TBL] [Abstract][Full Text] [Related]
19. Calcium channel blockade as primary therapy for stable angina pectoris. A double-blind placebo-controlled comparison of verapamil and propranolol.
Subramanian VB; Bowles MJ; Davies AB; Raftery EB
Am J Cardiol; 1982 Nov; 50(5):1158-63. PubMed ID: 6127945
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of sustained-release diltiazem in stable angina pectoris.
Weiner DA; Cutler SS; Klein MD
Am J Cardiol; 1986 Jan; 57(1):6-9. PubMed ID: 3510525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
